Form 4: Director Steven H. Collis Acquires Bausch + Lomb Shares

Director Steven H. Collis acquired 1,415 restricted share units of Bausch + Lomb Corporation on April 30, 2026.

Summary

• Director Steven H. Collis acquired 1,415 restricted share units (RSUs) of Bausch + Lomb Corporation (BLCO).
• The transaction occurred on April 30, 2026, at a price of $15.90 per share.
• Following this transaction, the reporting person's total beneficial ownership increased to 26,161 common shares.
• Each RSU represents a contingent right to receive one common share of the company.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine disclosure of director equity compensation.

Positives

• Director alignment with shareholder interests through increased equity ownership.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

Not applicable as this is a routine insider transaction filing.

Industry Context

StockSavvy.ai notes that routine director equity acquisitions are standard corporate governance practices intended to align leadership incentives with long-term shareholder value.

Comparison to Industry Standards

• The acquisition of equity by board members is a common practice across the pharmaceutical and medical device sectors to demonstrate confidence in company strategy.

Stakeholder Impact

• Positive signal for shareholders regarding director commitment.

Next Steps

• None mentioned.

Key Dates

Keywords

Bausch + Lomb, BLCO, Insider Trading, Form 4, Director Ownership